Current market price and purchase reference instructions for Lurbinectedin

Lurbinectedin (Lurbinectedin), as a new anti-tumor drug for the treatment of recurrent small cell lung cancer (SCLC), has been approved for marketing in China. However, the specific retail price in the domestic market has not yet been fully announced. Patients still need to consult local medical institutions or hospital pharmacies to obtain the latest price information when purchasing in hospitals or pharmacies. Because it is a high-priced anti-cancer drug, its use may be expensive, and medical insurance coverage and reimbursement ratios need to be confirmed according to local policies.

In the Hong Kong market, the price of Rubicatin’s original drug is relatively clear. Taking the 4mg box as an example, the price is approximately 2 more than 10,000 yuan. However, due to exchange rate fluctuations and drug supply channels, the price may be adjusted over time. For patients who need to obtain drugs through overseas channels, the Hong Kong version provides a more convenient purchase reference, but factors such as transportation, supervision and prescription restrictions still need to be considered.

In other overseas markets, the price of Rubicatin original drug varies greatly. The price of each box of the American version is about 90,000 yuan, and the Singapore version is about 3 more than 10,000 yuan. Price differences are mainly affected by local market pricing policies, pharmaceutical import taxes and exchange rate fluctuations. It is worth noting that there are currently no generic drugs of Rubicatin on the overseas market. If patients choose to purchase drugs overseas, they are all original drugs, which are relatively expensive.

When purchasing Rubicatin, patients should give priority to regular hospitals or legal overseas pharmacy channels to ensure reliable drug sources and drug quality and safety. At the same time, a reasonable drug purchase plan should be formulated based on personal financial capabilities, medical insurance policies and treatment plans. For patients undergoing long-term treatment, understanding price information and payment methods in advance can help ensure continuity of treatment and reduce financial pressure caused by drug price fluctuations.

Reference materials:https://www.drugs.com/